Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7290 | 0.95 | — | — | |
| Fluoride SCHEMBL22032641 | 0.90 | — | — | |
| SCHEMBL2575860 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL2188465 | 0.90 | — | — | |
| Bromide SCHEMBL2188976 | 0.90 | — | — | |
| Hydrogen Sulfide SCHEMBL28135424 | 0.90 | — | — | |
| Bromide SCHEMBL29384080 | 0.90 | — | — | |
| Trimethylammonium SCHEMBL27480270 | 0.82 | CYP2D6 (0.47) | — | |
| Dimethylamine SCHEMBL28393657 | 0.79 | CYP2D6 (0.44) | — | |
| Trimethylammonium SCHEMBL28396613 | 0.79 | CYP2D6 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025082611-A1 | COLLOIDAL ION-CAPPED PB CHALCOGENIDE NANOCRYSTALS FOR X-RAY APPLICATIONS | QDI SYSTEMS B.V (NL) | 2025-04-24 | — | — | WO | claimed |
| WO-2025082614-A1 | COLLOIDAL ION-CAPPED PB CHALCOGENIDE NANOCRYSTALS FOR SWIR APPLICATIONS | QDI SYSTEMS B.V (NL) | 2025-04-24 | — | — | WO | claimed |
| WO-2025082614-A1 | COLLOIDAL ION-CAPPED PB CHALCOGENIDE NANOCRYSTALS FOR SWIR APPLICATIONS | QDI SYSTEMS B.V (NL) | 2025-04-24 | — | — | WO | disclosed |
| WO-2025082611-A1 | COLLOIDAL ION-CAPPED PB CHALCOGENIDE NANOCRYSTALS FOR X-RAY APPLICATIONS | QDI SYSTEMS B.V (NL) | 2025-04-24 | — | — | WO | disclosed |
| WO-2024011061-A2 | COMPOSITIONS AND METHODS TO DETECT AUTOIMMUNE ANTIBODIES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-01-11 | — | — | WO | disclosed |
| CN-115942757-A | A-site doped halide perovskite type solar cell and preparation method thereof | 暨南大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-107501110-A | Fumarate pro-drug and its application in a variety of diseases are treated | 阿尔克梅斯制药爱尔兰有限公司 | 2017-12-22 | — | — | CN | disclosed |
| CN-105452213-B | Fumarate prodrugs and their use in the treatment of various diseases | 阿尔克梅斯制药爱尔兰有限公司 | 2017-09-22 | — | — | CN | disclosed |
| WO-2012058031-A2 | NOVEL METHOD FOR PREPARATION OF BISNORCYMERINE AND SALTS THEREOF | QR PHARMA, INC. (US) | 2012-05-03 | — | — | WO | disclosed |
| EP-2403848-A1 | PHARMACEUTICAL HYPOCHOLESTEROLEMIC COMPOSITIONS | Lipideon Biotechnology AG (CH) | 2012-01-11 | — | — | EP | disclosed |
| EP-2341886-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-07-13 | — | — | EP | disclosed |
| WO-2010100255-A1 | PHARMACEUTICAL HYPOCHOLESTEROLEMIC COMPOSITIONS | LIPIDEON BIOTECHNOLOGY AG (CH) | 2010-09-10 | — | — | WO | disclosed |
| WO-2010054269-A1 | ANTIMICROBIAL N-CHLORINATED COMPOSITIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-05-14 | — | — | WO | disclosed |
| US-4589977-A | HYDROCRACKING CATALYST | CHEVRON RESEARCH COMPANY (US) | 1986-05-20 | — | — | US | disclosed |
| US-4510256-A | CATALYST AND ADSORBENT | CHEVRON RESEARCH COMPANY (US) | 1985-04-09 | — | — | US | disclosed |